QA: EXICURE INC. in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001698530_2022_EXICURE_INC.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001698530, EXICURE INC.

  xvar xval
0 AssetsCurrent 43,666,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 3,927,000
3 remainder_Assets 17,275,000
4 LiabilitiesCurrent 34,067,000
5 LiabilitiesNoncurrent 19,569,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 13,087,000
9 ResearchAndDevelopmentExpense 48,979,000
10 remainder_Expenses 0
11 remainder_Revenues -483,000
12 remainder_NetIncome -1,553,000
13 remainder_ComprehensiveNetIncome -85,000
  yvar yval
0 Assets 64,868,000
1 Liabilities 53,636,000
2 Expenses 62,066,000
3 Revenues -483,000
4 StockholdersEquity 11,232,000
5 NetIncome -64,102,000
6 ComprehensiveNetIncome -64,144,500
7 BaseVar 91,345,500
8 EconomicCapitalRatio -0.757

Edgar->Model Mapping

Feature Distribution

Change over Time